Bisphosphonates modulate the effect of macrophage-like cells on osteoblast

International Journal of Biochemistry and Cell Biology

Volumn 34, Issue 5, 2002, Pages 554-563

  Evans, C E ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Bisphosphonates; Cell culture; Osteoblast and macrophages

Indexed keywords

ALKALINE PHOSPHATASE; BISPHOSPHONIC ACID DERIVATIVE; CYTOKINE; LACTATE DEHYDROGENASE;

ARTHRITIS; ARTICLE; BONE DISEASE; CELL COUNT; CELL CULTURE; CELL DEATH; CELL INTERACTION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME RELEASE; HUMAN; HUMAN CELL; IMPLANT; MACROPHAGE; OSTEOBLAST; OSTEOLYSIS; PROTEIN SYNTHESIS INHIBITION;

ALKALINE PHOSPHATASE; CELLS, CULTURED; COCULTURE TECHNIQUES; DIPHOSPHONATES; HUMANS; MACROPHAGES; OSTEOBLASTS;

EID: 0036131468     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(01)00147-9     Document Type: Article

References (65)

1. Wear and osteolysis in total joint replacements
2. Macrophage activation results in bone resorption
3. Soluble factors secreted by macrophage in vitro cause osteoprogenitor cells to dead here
4. The origin of osteoclasts: Evidence, clinical implications and investigative challenges of an extra-skeletal source
5. Phagocytic defects - Monocytes/macrophages
6. Diphosphonates inhibit bone resorption by macrophages in vitro
7. 2MDP) on rat macrophage-mediated bone resorption in vitro
8. Bisphosphonates in vitro specifically inhibit among the hematopoietic series, the development of the mouse mononuclear phagocyte lineage
9. Bisphosphonates induce apoptosis in mouse macrophage-like cells in-vitro by a nitric oxide-independent mechanism
10. Bisphosphonates - History and experimental basis
11. Bisphosphonates in the treatment of disorders of mineral metabolism
12. Bisphosphonates and the treatment of bone disease in the elderly
13. Bisphosphonate action: Alendronate localization in rat bone and effects on osteoblast ultrastructure
14. Effects of tiludronate on bone mass, structure and turnover at the epiphyseal, primary and secondary spongiosa in the proximal tibia of growing rats after sciatic neurectomy
15. Effects of dichloromethylene diphosphonate in women with breast cancer metastatic to the skeleton
16. Reduced morbidity from skeletal metastases in breast cancer during long term bisphosphonates (APD) treatment
17. Management of myeloma with bisphosphonates
18. Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma
19. Bisphosphonates in multiple myeloma: Current status; future perspectives
20. Maintained improvement in calcium balance and bone mineral content in patients treated with the bisphosphonate APD
21. Short-term effects of pamidronate on biochemical markers of bone metabolism in osteoporosis - A placebo-controlled dose-finding study
22. Pathogenesis and management of cancer associated hypercalcaemia
23. Hypercalcaemia and bone resorption in malignancy
24. Efficacy and safety of drugs for Paget's disease of bone
25. Effects of dichloromethylene diphosphonate on skeletal mosteoblastilisation of calcium in multiple myeloma
26. Biological and clinical assessment of a new bisphosphonate (chloro-4-phenyl) thiomethylene bisphosphonate in the treatment of Paget's disease of bone
27. Alendronate modulates osteogenesis of human osteoblastlastic cells in vitro
28. Effects of bisphosphonates APD and HEBP on bone metabolism in vitro
29. 2 synthesis in the clonal osteoblastlast-like cell line MC3T3-E1
30. Effects of two novel bisphosphonates on bone cells in vitro
31. The use of various techniques in the removal of haemopoietic cells from explant cultures of rabbit bone in vivo: A constructive comparison
32. In vitro proliferation of cells cultured from human cancellous bone
33. 3,PTH and glucocorticoids
34. Effect of donor age on the growth in vitro of cells osteoblasttained from human trabecular bone
35. The effect of cyclic pressure on human monocyte-derived macrophages in vitro
36. Rapid, colourimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assay
37. A sensitive method for assay of phosphatases using dinitrophenol
38. Effect of bisphosphonates on proliferation and viability if mouse bone marrow-derived macrophages
39. 1-gamma-dichloromethylene) triphosphate, by mammalian cells in vitro
40. Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras
41. Regulation of bone cells by particle-activated mononuclear phagocytes
42. Macrophages release a peptide stimulator of osteoblastlast growth
43. Intramembraneous and endochondrial bone changes induced by a new bisphosphonate (YM175) in the beagle dog
44. Effects of bisphosphonates and inorganic pyrophosphate on osteogenesis in vitro
45. Differential response of bone cells isolated by sequential digestion to dichloromethylene bisphosphonate
46. Effect of halogenmethyl-bisphosphonates on bone cells in culture and on bone resorption in vivo
47. 3-Amino-1-hydroxypropylidene-1-bisphosphonate (AHPrBP) suppresses not only the induction of new, but also the persistence of existing bone-forming surfaces in rat cancellous bone
48. Influence of monocyte-macrophage lineage cells on alkaline phosphatase activity of developing osteoblast derived from rat bone marrow stromal cells
49. Determined and inducible osteogenic precursor cells
50. Migration and phenotypic transformation of osteoblast precursors into mature osteoclasts: The effect of a bisphosphonate
51. Bisphosphonates directly inhibit the bone resorption activity of isolated avian osteoclasts in vitro
52. Bisphosphonate inhibition of bone resorption induced by particulate biomaterial-associated macrophages
53. Effects of tiludronate and ibandronate on the secretion of proinflammatory cytokines and nitric oxide from macrophages in vitro
54. Effect of liposomal and free bisphosphonates on the IL-1 beta, IL-6 and TNF alpha secretion from RAW 264 cells in vitro
55. Inhibition of antigen-presenting cell function by alendronate in vitro
56. The effect of alendronate on cytokine production adhesion molecule expression and transendothelial migration of human peripheral blood mononuclear cells
57. Contrasting effects of an aminosteoblastisphosphonate, a potent inhibitor of bone resorption, on lipopolysaccharide-induced production of interleukin-1 and tumour necrosis factor alpha in mice
58. Enhancement by galactosamine of lipopolysaccharide(LPS)-induced tumour necrosis factor production and lethality: Its suppression by LPS pretreatment
59. Pharmacologic inhibition of particulate-induced bone resorption
60. Effects of alendronate on the osteoclastogenic potential of bone marrow cells in mice
61. Alendronate reduces particle induced cytokine production in macrophages
62. Alendronate prevents bone resorption by isolated cells from periprosthetic granulation tissue in hips of revision total hip arthroplasty
63. Clodronate (dichloromethylene bisphosphonate) inhibits LPS-stimulated IL-6 and TNF production by Raw 264 cells
64. Alendronate but not clodronate, inhibits protein prenylation in vivo